Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Risk Factors of Beta-Lactam Drugs Related Acute Kidney Injury in Hospitalized Patients and Developments of Machine Learning Model

NCT05533606 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05533606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05533606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Risk Factors of Beta-Lactam Drugs Related Acute Kidney Injury in Hospitalized Patients and Developments of Machine Learning Model
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2022
Completion date
June 30, 2023
Enrollment
19,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, beta-lactam antibiotic toxicity (diagnosis)